about
Lymphocyte subsets in term and significantly preterm UK infants in the first year of life analysed by single platform flow cytometryUnsuspected Pneumocystis carinii pneumonia at presentation of severe primary immunodeficiencyDevelopment of the preterm gut microbiome in twins at risk of necrotising enterocolitis and sepsisThe neonatal bowel microbiome in health and infection.Preterm gut microbiota and metabolome following discharge from intensive careLactoferrin: Antimicrobial activity and therapeutic potential.Cytomegalovirus and other common enteric viruses are not commonly associated with NEC.Evaluating the feasibility of integrating salivary testing for congenital CMV into the Newborn Hearing Screening Programme in the UK.Emergency EXIT for preterm labour after FETO.Duodenal stenosis associated with weakness of sphincter of Oddi.Feasibility and acceptability of targeted screening for congenital CMV-related hearing loss.Clinically targeted screening for congenital CMV - potential for integration into the National Hearing Screening Programme.The changing profile of infant mortality from bacterial, viral and fungal infection over two decades.Avidity of Haemophilus influenzae type b antibody in UK infantsProportionate reduction in uncertainty of late onset infection in pre-term infants by neutrophil CD64 measurement.Viral infections: contributions to late fetal death, stillbirth, and infant death.Successful blood salvaging from preterm infants: maximizing opportunities, minimizing interventions.Probiotics reduce the risk of necrotising enterocolitis (NEC) in preterm infants.Gut microbiota in preterm infants: assessment and relevance to health and disease.Determining the ventilatory volumes required to ventilate low birth weight infants with respiratory distress syndrome. Prediction of arterial carbon dioxide using minute volumes.Retinopathy of prematurity screening at ≥30 weeks: urinary NTpro-BNP performance.Bacterial and fungal viability in the preterm gut: NEC and sepsis.The preterm gut microbiota: changes associated with necrotizing enterocolitis and infectionDeaths in Preterm Infants: Changing Pathology Over 2 DecadesOral ibuprofen for the treatment of patent ductus arteriosus: further clarificationFlu vaccination for ex-preterms and infants under 6 months--are we getting it right?Reduced anti-PRP antibody response to Hib immunisation in preterm (<32 weeks) UK infants who received inactivated polio (eIPV)Haemophilus influenzae Type b Immunization in Infants in the United Kingdom: Effects of Diphtheria/Tetanus/Acellular Pertussis/Hib Combination Vaccine, Significant Prematurity, and a Fourth DoseImmunization Responses in Preterm Infants Who Receive Postnatal Steroid TreatmentTwo speeds of increasing milk feeds for very preterm or very low-birthweight infants: the SIFT RCT
P50
Q24684147-68932C58-5DB8-41B9-8219-B3FB5DB2CAFFQ33825027-BFDDE664-BC95-44C3-B262-19E818CFED98Q34983739-60B5817F-EC7A-4092-9C66-5206C680016AQ35153977-81B95668-28D1-4AF1-8137-53FFEC679987Q35849381-C7A29C09-ECF2-4C62-9A15-931FA70CEC2EQ38090855-5D55EC13-DF63-4F72-8B14-4457643371CDQ41120736-A6C17FCF-9522-41DE-8538-5933731E052DQ41447827-27E38FB5-C2FB-4F03-998E-580E0A7C3810Q41987953-A1134B8B-22D5-4034-96CA-23BF122F7F78Q42028332-8E3F1300-65B9-46A5-91A2-89A804FAD078Q42225631-290F890E-F96D-4F23-AB86-C24E34AB0D29Q42251916-B6A41CFA-5BC3-4FE3-A16C-7BEF75E799BBQ42256350-50A625BC-EFF7-4282-9AA6-726720D12CAEQ42571020-96388E15-6EFF-4E2D-ACBE-D8877A622BE4Q43497454-391E04AD-4BC3-4CE2-977B-57DB2EE15693Q43839264-C47C4955-B20A-4D83-B07D-9DA10DDAA284Q43855161-0268B122-F755-4B3A-ADC5-DC288523BBE5Q44547012-62190C53-E445-4C12-BFCF-F4771F9789DCQ46479326-2D84FB29-4B1E-47FC-8A7C-2A3DA3D54B00Q47176310-5D2F42B8-78F6-4198-A4AF-A0300CF8A7A4Q52805974-7F6BCA71-D0C4-4A3F-B083-3339A2EE8D76Q54271312-E9E88915-BD8A-4AEE-8876-9211BDA5BC72Q57241186-D2263C0D-7871-4057-B49C-3CF1957BE493Q61850575-3D73DEC5-F14F-49E4-A516-0F2660371EAFQ61850577-16A17512-F8C6-47AC-BD5B-4EBFA43E3ED4Q61850597-62868D5F-B2E8-422C-963A-8397A1F4047DQ61850599-E493EA99-621D-4D69-9823-1C937D7542EDQ61850601-7F2F8E70-0167-4434-8284-961E547DC6F2Q61850602-2CFFC911-D964-4577-8BE1-274015DAF8B6Q93334845-F05E8E53-32D4-4DF4-84B9-351E8998A8BE
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Janet Elizabeth Berrington
@ast
Janet Elizabeth Berrington
@en
Janet Elizabeth Berrington
@es
Janet Elizabeth Berrington
@nl
type
label
Janet Elizabeth Berrington
@ast
Janet Elizabeth Berrington
@en
Janet Elizabeth Berrington
@es
Janet Elizabeth Berrington
@nl
prefLabel
Janet Elizabeth Berrington
@ast
Janet Elizabeth Berrington
@en
Janet Elizabeth Berrington
@es
Janet Elizabeth Berrington
@nl
P106
P1153
6507298653
P21
P31
P496
0000-0002-6185-2843